•   English  
    • /
  •   中文
山东方坦思生物医药产业技术研究院有限公司
HOMEHome
WHO WE ARENav
WHAT WE DONav
INVESTORSNav
PIPELINENav
NEWSNav
CAREERSNav
CONTACT USNav
HISTORYLEADERSHIPADVISORSBOARD OF DIRECTORS
Fontacea supports Guzhang through alleviating poverty 		[ news ] 2020-06-24
Mr Yanliang Chu, chairman of Fontacea, signed Dr David Brooks as business consultant in USA 		[ news ] 2020-02-10
Mr Yanliang Chu, Chairman of Fontacea, signed Dr Timothy P. Coogan as the Medicine Safety Consultant 		[ news ] 2019-12-23
Senior leaders attended "Innovative Medicine Investment Seminar" 		[ news ] 2019-12-11
Shandong Fontacea is licensed for anti-IL17A monoclonal antibody from Janssen 		[ news ] 2019-09-10
Yanliang Chu, welcomes Mark Winnett as Management Consultant to Fontacea 		[ news ] 2019-08-12
Fontacea shareholder Lei Meng, chairman of Shandong development investment holding group co. LTD 		[ news ] 2019-07-17

to the end ~
©2020 -  Shandong Fontacea Pharmaceutical Institute Co.,Ltd copyright.